Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Histogen Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q2 2021
- Shares held
- 2.84M
- +99.0K (+3.6%) vs. Q2 2021
- Total value
- $2.15M
- −$835.3K (−27.9%) vs. Q2 2021
- New holders
- 4
- 10 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSTO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $6 |
| Q4 2023 | 1 | $5 |
| Q3 2023 | 9 | $9.53K |
| Q2 2023 | 13 | $107.8K |
| Q1 2023 | 14 | $211.1K |
| Q4 2022 | 13 | $90.4K |
| Q3 2022 | 13 | $174.0K |
| Q2 2022 | 10 | $229.0K |
| Q1 2022 | 23 | $1.00M |
| Q4 2021 | 25 | $2.76M |
| Q3 2021 | 22 | $2.15M |
| Q2 2021 | 24 | $2.99M |
| Q1 2021 | 26 | $2.18M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Histogen Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 987,924 | $749.0K | 0.00% | +25,195+2.6% | Added |
| BlackRock Inc. | 698,234 | $529.0K | 0.00% | +10,033+1.5% | Added |
| Geode Capital Management, LLC | 207,892 | $157.0K | 0.00% | +34,649+20.0% | Added |
| State Street Corp | 172,200 | $130.0K | 0.00% | 00.0% | Unchanged |
| Meitav Dash Investments Ltd | 124,000 | $94.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 104,321 | $79.0K | 0.01% | +40,850+64.4% | Added |
| Northern Trust Corp | 90,026 | $68.0K | 0.00% | +69,320+334.8% | Added |
| United Capital Financial Advisers, LLC | 79,987 | $61.0K | 0.00% | 00.0% | Unchanged |
| Natixis | 79,800 | $60.0K | 0.00% | −9,100−10.2% | Reduced |
| Millennium Management LLC | 71,227 | $54.0K | 0.00% | −171−0.2% | Reduced |
| Two Sigma Securities, LLC | 52,289 | $40.0K | 0.01% | +29,019+124.7% | Added |
| Newman Dignan & Sheerar, Inc. | 52,522 | $40.0K | 0.01% | +52,522 | New |
| IPG Investment Advisors LLC | 40,000 | $30.3K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 34,440 | $26.0K | 0.00% | −60,510−63.7% | Reduced |
| Advisor Group Holdings, Inc. | 12,825 | $10.0K | 0.00% | +7,525+142.0% | Added |
| Two Sigma Advisers, LP | 13,400 | $10.0K | 0.00% | +13,400 | New |
| Susquehanna International Group, LLP | 11,458 | $9.00K | 0.00% | +11,458 | New |
| Tower Research Capital LLC (TRC) | 6,702 | $5.00K | 0.00% | +6,702 | New |
| Prentice Wealth Management LLC | 1,000 | $1.00K | 0.00% | −1,000−50.0% | Reduced |
| Bank of America Corp | 1,464 | $1.00K | 0.00% | +1,449+9,660.0% | Added |
| Wells Fargo & Company | 329 | $0 | 0.00% | +56+20.5% | Added |
| Morgan Stanley | 51 | $0 | 0.00% | +1+2.0% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −92,721−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −31,344−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,097−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |